My Quote Request
6505-01-135-4251
20 Products
NDC00904-2920-60
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
NDC00904-2920-60
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00047-0328-24
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
NDC00047-0328-24
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
MFG
WARNER-CHILCOTT LABORATORIES DIV OF WARNER-LAMBERT PHARMACEUTICAL CO CUSTOMER SERVICE DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0512-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
NDC00378-0512-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-4812-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
NDC00536-4812-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-4931-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
NDC00536-4931-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-0343-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
NDC00591-0343-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
MFG
WATSON LABS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1016-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
NDC00781-1016-01
VERAPAMIL TABLETS,USP
NSN, MFG P/N
6505011354251
NSN
6505-01-135-4251
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL TABLETS USP 80MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00054-8708-25
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505011354262
NSN
6505-01-135-4262
NDC00054-8708-25
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505011354262
NSN
6505-01-135-4262
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS
Related Searches:
LASIX
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011354263
NSN
6505-01-135-4263
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 80MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS PER PACKAGE
Related Searches:
NDC00039-0066-11
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011354263
NSN
6505-01-135-4263
NDC00039-0066-11
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011354263
NSN
6505-01-135-4263
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 80MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS PER PACKAGE
Related Searches:
NDC00378-0232-01
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011354263
NSN
6505-01-135-4263
NDC00378-0232-01
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011354263
NSN
6505-01-135-4263
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 80MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS PER PACKAGE
Related Searches:
NDC00781-1446-01
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011354263
NSN
6505-01-135-4263
NDC00781-1446-01
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011354263
NSN
6505-01-135-4263
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 80MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS PER PACKAGE
Related Searches:
11-987
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
11-987
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.030 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 136.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 39.220 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART OF SOLUTION WITH 34 PARTS OF DEIONIZED WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: 2.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
12-825
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
12-825
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.030 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 136.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 39.220 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART OF SOLUTION WITH 34 PARTS OF DEIONIZED WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: 2.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
6505-00-C99-3277
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
6505-00-C99-3277
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.030 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 136.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 39.220 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART OF SOLUTION WITH 34 PARTS OF DEIONIZED WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: 2.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
RENALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
RENALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011354265
NSN
6505-01-135-4265
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.030 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 136.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 39.220 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART OF SOLUTION WITH 34 PARTS OF DEIONIZED WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: 2.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
NDC00731-0401-06
ZINC SULFATE CAPSULES
NSN, MFG P/N
6505011354992
NSN
6505-01-135-4992
NDC00731-0401-06
ZINC SULFATE CAPSULES
NSN, MFG P/N
6505011354992
NSN
6505-01-135-4992
MFG
ALTO PHARMACEUTICALS INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 220.000 MILLIGRAMS ZINC SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC50419-0127-12
EPINEPHRINE INJECTABLE OIL SUSPENSION,USP
NSN, MFG P/N
6505011355070
NSN
6505-01-135-5070
NDC50419-0127-12
EPINEPHRINE INJECTABLE OIL SUSPENSION,USP
NSN, MFG P/N
6505011355070
NSN
6505-01-135-5070
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS EPINEPHRINE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC50419-0137-12
EPINEPHRINE INJECTABLE OIL SUSPENSION,USP
NSN, MFG P/N
6505011355070
NSN
6505-01-135-5070
NDC50419-0137-12
EPINEPHRINE INJECTABLE OIL SUSPENSION,USP
NSN, MFG P/N
6505011355070
NSN
6505-01-135-5070
MFG
FOREST PHARMACEUTICALS INC SUB OF FOREST LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS EPINEPHRINE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00223-0630-01
CHLORTHALIDONE TABLETS,USP
NSN, MFG P/N
6505011355696
NSN
6505-01-135-5696
NDC00223-0630-01
CHLORTHALIDONE TABLETS,USP
NSN, MFG P/N
6505011355696
NSN
6505-01-135-5696
MFG
CONSOLIDATED MIDLAND CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORTHALIDONE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORTHALIDONE TABLETS USP 25MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1